NCT06133998

Brief Summary

Effects of Incentive spirometry with and without Aerobic exercises on dyspnea, exercise capacity and quality of life in interstitial lung disease

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 25, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2023

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

2 months

First QC Date

October 25, 2023

Last Update Submit

November 15, 2023

Conditions

Keywords

shortness of breath ,cough,fatigue.

Outcome Measures

Primary Outcomes (6)

  • FVC (force vital capacity)

    Pulmonary function tests (PFTs) are noninvasive tests that show how well the lungs are working. The tests measure lung volume, capacity, rates of flow, and gas exchange. Spirometry the most common type of lung function test. It measures how much and how quickly you can move air in and out of your lungs. Measure the values of FVC (force vital capacity) in liters and in predicted % form . Normal value of FVC is 4.75 to 5.5 in male and 3.25 to3.75 in female.

    6 weeks

  • The value of FEV1

    Pulmonary function tests (PFTs) are noninvasive tests that show how well the lungs are working. The tests measure lung volume, capacity, rates of flow, and gas exchange. Spirometry the most common type of lung function test. It measures how much and how quickly you can move air in and out of your lungs. Measure the value of FEV1 in liters and in predicted% form. Normal FEV1 in male is3.5to 4.5 and in female is 2.5 to 3.25.

    6 weeks

  • Borg scale

    This scale use for the measurement of dyspnea (shortness of breath) Borg rating of perceived exertion (RPE) is an outcome measure scale used in knowing exercise intensity prescription. It is used in monitoring progress and mode of exercise in cardiac patients as well as in other patient populations undergoing rehabilitation and endurance training. According to the Borg scale maximum value is 9-10which shows the severe pain level in patient and the moderate pain value is 3-4 the minimum pain is values 1-2 .

    6 weeks

  • 6mint walk test

    This test is performing for the measurement of aerobic capacity and endurance. The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity

    6 weeks

  • Quality of life questioner

    This questioner is use for measure of physical, psychological and emotional wellbeing life. The QOLQ is a validated and reliable questionnaire that measures an individual's physical, psychological, and social well-being. It consists of a set of questions that cover various aspects of quality of life, such as physical health, emotional well-being, social support, and overall satisfaction with life

    6 weeks

  • chest expansion

    In this test we use the measuring tape for the measurement of chest mobility. Chest expansion, defined as the difference in thoracic girth after maximum inspiration and maximum expiration, is one indicator of chest wall mobility. As it is measured using a measuring tape, it is a simple, inexpensive, and noninvasive tool for assessing chest mobility.

    6 weeks

Study Arms (2)

incentive spirometry with aerobic exercises

EXPERIMENTAL

Group A: Aerobic exercise (running, jugging, cycling, walking) will be given to the group A for the checking the effect of incentive spirometer * In sitting position, for the relaxation of body, patient will take a deep breath. * In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung. * This schedule will be following supervised exercise training for a minimum 60 minutes 3 days a week in moderate patient,75 minutes in moderate to vigorous patients and 150 minutes in healthy patients * We will check the dyspnea of the patient by the borage scale * We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test * We will check the quality of life by the questionnaire.

Device: incentive spirometer with aerobic exercises

incentive spirometry without aerobic exercises

ACTIVE COMPARATOR

Group B: In group B we will check the effects of incentive spirometer without the aerobic exercise. * In aerobic exercise following treatment protocol will be involve * In sitting position, for the relaxation of body, patient will take a deep breath. * In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung. * We will check the dyspnea of the patient by the borage scale * We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test * We will check the quality of life by the questionnaire. * We will check the chest expansion by measuring tap.

Device: incentive spirometry without aerobic exercises

Interventions

Group A: Aerobic exercise (running, jugging, cycling, walking) will be given to the group A for the checking the effect of incentive spirometer * In sitting position, for the relaxation of body, patient will take a deep breath. * In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung. This schedule will be following supervised exercise training for a minimum 60 minutes 3 days a week in moderate patient,75 minutes in moderate to vigorous patients and 150 minutes in healthy patients * We will check the dyspnea of the patient by the borage scale * We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test * We will check the quality of life by the questionnaire.

incentive spirometry with aerobic exercises

Group B: In group B we will check the effects of incentive spirometer without the aerobic exercise. * In aerobic exercise following treatment protocol will be involve * In sitting position, for the relaxation of body, patient will take a deep breath. * In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung. * We will check the dyspnea of the patient by the borage scale * We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test * We will check the quality of life by the questionnaire. * We will check the chest expansion by measuring tap.

incentive spirometry without aerobic exercises

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All patients18 to 55 years of age (21)
  • Both gender(M/F)
  • Diagnosed as ILD ( sarcoidosis,acute interstitial pneumonia etc.)on clinical, radiological, and histopathological basis
  • All included patients were clinically stable without exacerbations in the past 1 month.

You may not qualify if:

  • Patients with other significant respiratory disorders such as acute infections, pulmonary tuberculosis, COPD, asthma, bronchiectasis, lung carcinoma, and pneumothorax
  • connective tissue disease-associated ILD
  • Patients having other co morbid diseases preventing from exercise training, for example, disability due to orthopedic, neurological, and acute cardiac causes
  • Physically and mentally unwell to attend the hospital for training
  • Already completed or participated in a PR program in the past 1 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ittefaq Hospital

Lahore, Punjab Province, 042, Pakistan

RECRUITING

Related Publications (5)

  • Bilyy A, El-Nakhal T, Kadlec J, Bartosik W, Tornout FV, Kouritas V. Preoperative training education with incentive spirometry may reduce postoperative pulmonary complications. Asian Cardiovasc Thorac Ann. 2020 Nov;28(9):592-597. doi: 10.1177/0218492320957158. Epub 2020 Sep 11.

    PMID: 32915659BACKGROUND
  • Larson M, Kim MJ. Respiratory muscle training with the incentive spirometer resistive breathing device. Heart Lung. 1984 Jul;13(4):341-5.

    PMID: 6564101BACKGROUND
  • Scherer TA, Spengler CM, Owassapian D, Imhof E, Boutellier U. Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life. Am J Respir Crit Care Med. 2000 Nov;162(5):1709-14. doi: 10.1164/ajrccm.162.5.9912026.

    PMID: 11069801BACKGROUND
  • Ho SC, Chiang LL, Cheng HF, Lin HC, Sheng DF, Kuo HP, Lin HC. The effect of incentive spirometry on chest expansion and breathing work in patients with chronic obstructive airway diseases: comparison of two methods. Chang Gung Med J. 2000 Feb;23(2):73-9.

    PMID: 10835801BACKGROUND
  • Rondinel TZ, Correa IF, Hoscheidt LM, Bueno MH, Da Silva LM, Reppold CT, Dal Lago P. Incentive spirometry combined with expiratory positive airway pressure improves asthma control and quality of life in asthma: a randomised controlled trial. J Asthma. 2015 Mar;52(2):220-6. doi: 10.3109/02770903.2014.956890. Epub 2014 Sep 2.

    PMID: 25144550BACKGROUND

MeSH Terms

Conditions

Lung Diseases, InterstitialFatigue

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • sumera abdul hameed, Ms

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2023

First Posted

November 18, 2023

Study Start

September 20, 2023

Primary Completion

December 1, 2023

Study Completion

December 10, 2023

Last Updated

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations